Dear Zacks.com Visitor,
I invite you to download a free Special Report that names 5 tickers, each tabbed by a Zacks expert to gain +100% and more in the next 12 months.
One company announced a cancer breakthrough that scored a 79% increase in progression-free survival in Phase III testing. Another is set to gain steam from a $3.45 billion acquisition. Still another has room for price increases that could send margins through the roof. Don't miss these stocks with compelling gain potential.